Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

NARecruitingINTERVENTIONAL

Enrollment

194

Participants

Timeline

Start Date

January 11, 2019

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions

Early Hormone Receptor-positive Breast Cancer

Interventions

DRUG

Chemotherapy Drugs, Cancer

Clinical high and genomic low Hormone Receptor-positive early breast cancer patients with or without adjuvant chemotherapy

Trial Locations (1)

RECRUITING

Samsung Medical Center, Seoul